The global 3D ultrasound market size was valued at USD 2.9 billion in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 6.6% from 2020 to 2027. The key drivers of the market are the increasing incidence of target disease, the rising number of diagnostic centers, and a growing preference for minimally invasive procedures. Moreover, technological advancements in 3D imaging have helped in improving diagnosis by providing immediate clinical information and also helped in reducing healthcare costs. The 3D imaging technology capabilities have spread across all clinical applications from cardiology, gynecology & obstetrics to an emergency point of care. The cost-effectiveness, speed, and efficacy nature of 3D imaging are some of the added advantages over other imaging modalities. In terms of technology, 3D ultrasound imaging is going through an evolution of miniaturization.
3D ultrasound imaging has the potential to provide real-time imaging of the anatomical structure. Real-time 3D ultrasound has more advantages for guiding interventional procedures. These devices can visualize real-time tissue organs in 3D. Moreover, 3D ultrasound has a better acquisition rate of 30 volumes per second compared with volumetric imaging alternatives including CT and MRI. Thus, it is expected to improve clinical outcomes and also reduce the patient’s hospital costs.
The rising number of product launches and FDA approval for 3D technologies are also boosting growth. For instance, in May 2020, Philips Healthcare (Amsterdam, Holland) received FDA approval to market its ultrasound solution for the management of COVID-19-related cardiac and lungs complication. Moreover, artificial intelligence-guided 3D imaging is also expected to drive the market for 3D ultrasound. For instance, in February 2020, Caption Health received the FDA approval for an ultrasound software that guides clinicians in capturing images of the heart.
Cart/trolley-based devices dominated the market and accounted for a revenue share of 80.0% in 2019. The high usage of these devices and the increasing number of product launches are contributing to the growth of the market. For instance, in July 2020, Hologic, Inc. launched SuperSonic Mach 40, a cart-based ultrasound system in the U.S. Rising healthcare expenditure and the increasing number of hospital admission due to various cardiac and pulmonary diseases are also boosting the demand for the segment.
The handheld segment is expected to witness a CAGR of 8.2% during the forecast period. Improvement in ease of use has been an essential factor in the growth of POC 3D ultrasound imaging. Many companies are focusing on the development of a handheld ultrasound system that can easily be transported anywhere. For instance, in November 2015, Philip Healthcare opened a new point of care segment. The company launched Lumify, a mobile-based ultrasound system.
The general imaging segment dominated the market for 3D ultrasound and accounted for a revenue share of 29.4% in 2019. Rising adoption of these devices and an increasing number of product launches are driving the growth. For instance, in February 2018, GE Healthcare launched LOGIQ E10, an AI-based radiology ultrasound system designed to produce high-quality images for various body parts, including the heart, testes, thyroid, abdomen, breast, and liver. The cardiac 3D ultrasound segment also accounts for a considerable amount of market share. The evolution of transcatheter procedures such as Tricuspid Valve Repair (TTVR), Transcatheter Aortic Valve Replacement (TAVR), and transcatheter mitral valve repair (TMVR) used to repair structured cardiac disease, has led to growth in the preoperative planning market.
The point of care ultrasound segment is expected to grow at the fastest rate owing to the increasing usage of these devices in hospitals and clinics. With lower system costs and miniaturization of technology, the demand for point-of-care ultrasound is expected to increase. Major clinical application of point of care 3D ultrasound systems is cardiac/critical care, musculoskeletal, emergency medicine (urgent and hospital-based), anesthesia, and pain management. The segment has shown significant growth in musculoskeletal applications due to the ability to visualize soft tissue in joint space, ligaments, tendons, and muscles.
North America accounted for the largest market share of 27.3% in 2019 and is expected to maintain its dominance over the forecast period. Regionally, the market for 3D ultrasound is segmented into North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. The increasing number of product launches and favorable reimbursement are the factors contributing to North America's dominance. The region is also witnessing continuous technological advancement in the field of 3D imaging. Moreover, increasing research and development expenses and a rising patient pool are also boosting the market growth.
In Asia Pacific, the market for 3D ultrasound is likely to witness the fastest growth rate during the forecast period. A rising patient pool and a rising preference for minimally invasive surgeries are contributing to the growth. The use of ultrasound outside of traditional core applications; cardiology radiology, and women’s health remained underuse in the developing market. As a result, there is a high expectation that new users of 3D ultrasound imaging would increase the demand in the region.
The market for 3D ultrasound was dominated by GE Healthcare with an approximate market share of 35.0% in 2019. The major players in industries are heavily investing in research and development and are continuously innovating their present offerings. For instance, in July 2020, Hoya Corp and Hitachi, Ltd. announced a five-year contract for an endoscopic ultrasound system to strengthen their technical collaboration. The major players in the industries are focusing on the miniaturization of devices with a better visualization. Companies are also focusing on providing tools for 3D technologies, such as multiplanar display, which helps in rendering a better view. Moreover, companies are also focusing on the implementation of artificial intelligence technology in 3D ultrasound. Some of the prominent players in the 3D ultrasound market include:
Market size value in 2020
USD 3.1 billion
Revenue forecast in 2027
USD 4.8 billion
CAGR of 6.6% from 2020 to 2027
Base year for estimation
2016 - 2018
2020 - 2027
Revenue in USD million and CAGR from 2020 to 2027
Revenue forecast, company share, competitive landscape, growth factors, and trends
Application, end-use, region
North America; Europe; Asia Pacific; Latin America; Middle East & Africa
The U.S.; Canada; the U.K.; Germany; France; Italy; Spain; Russia; Japan; China; Malaysia; India; South Korea; Australia; Brazil; Mexico; Argentina; Colombia; South Africa; Saudi Arabia; UAE
Key companies profiled
GE Healthcare; Philips Healthcare; Canon; Hitachi; Siemens; Fujifilm
Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options
Avail customized purchase options to meet your exact research needs. Explore purchase options
This report forecasts revenue growth at global, regional, and country levels as well as provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2027. For the purpose of this study, Grand View Research has segmented the global 3D ultrasound market report based on application, end-use, and region.
Application Outlook (Revenue, USD Million, 2016 - 2027)
Obstetrics and gynecology
Point of care
End-use Outlook (Revenue, USD Million, 2016 - 2027)
Regional Outlook (Revenue, USD Million, 2016 - 2027)
Middle East & Africa
b. The global 3D ultrasound market size was estimated at USD 2.9 billion in 2019 and is expected to reach USD 3.1 billion in 2020.
b. The global 3D ultrasound market is expected to grow at a compound annual growth rate of 6.6% from 2020 to 2027 to reach USD 4.8 billion by 2027.
b. North America dominated the 3D ultrasound market with a share of 28.9% in 2019. This is attributable to rising healthcare awareness coupled with cloud-based technologies acceptance and constant research and development initiatives.
b. Some key players operating in the 3D ultrasound market include Teladoc; Doctor on Demand; iCliniq; IBM; Intel Corporation; Philips Healthcare; McKesson Corporation; AMD Telemedicine; GE Healthcare; CardioNet Inc.; 3m Health Information Systems; Medic4all; CirrusMD Inc.; Cisco; and American Telecare Inc.
b. Key factors that are driving the 3D ultrasound market growth include increasing medicare reimbursement for telehealth services, reducing emergency room visits and hospitalization rate, and technological innovation in communication technology across the world.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
"The quality of research they have done for us has been excellent."